Gustavo C Rodriguez MD
Gynecologic Oncology
Professor of Obstetrics & Gynecology, Northwestern University-Feinberg School of Medicine
Join to view full profile
2650 Ridge Ave.Kellogg Cancer CenterEvanston, IL 60201
Phone+1 847-570-2639
Fax+1 847-733-5618
Dr. Rodriguez is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Gustavo Rodriguez is a specialist in Obstetrics & Gynecology, with a subspecialty in Gynecologic Oncology, based in Evanston, IL. He graduated from the University of Illinois College of Medicine in 1985 and completed his residency there between 1985 and 1987. His expertise encompasses areas such as fallopian tube carcinoma, general obstetrics and gynecology, gynecologic oncology, cervical cancer, and minimally invasive gynecologic surgery. Dr. Rodriguez has contributed to several publications in the field and has been involved in clinical trials focused on ovarian, fallopian tube, or primary peritoneal cancer, among others. His commendable work has earned him multiple honors including the CMS Meaningful Use Stage 1 Certification and the Super Doctor award from SuperDoctors.com, as well as the Fellow (FACOG) from American Congress of Obstetricians and Gynecologists.
Education & Training
University of Illinois College of Medicine at ChicagoResidency, Obstetrics and Gynecology, 1985 - 1987- University of Illinois College of MedicineClass of 1985
Certifications & Licensure
IL State Medical License 1987 - 2029
NC State Medical License 1989 - 2003
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
- CMS Meaningful Use Stage 2 Certification Public Health Data Reporter, Medical Research Analytics and Informatics Alliance (MRAIA), 2011, 2013-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017
Clinical Trials
- CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells Start of enrollment: 2009 Apr 13
- Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain Start of enrollment: 2011 Sep 20
- Vitamin D for Women at Increased Risk of Developing Ovarian, Fallopian, or Primary Peritoneal Cancer
Publications & Presentations
PubMed
- 1 citationsProgestin and vitamin D synergistically inhibit fallopian tube carcinogenesis.Omar L Nelson, Rebecca Rosales, Jane Turbov, Larry G Thaete, Dillon Berlin
Gynecologic Oncology. 2026-05-01 - Retraction: Progesterone and calcitriol reduce invasive potential of endometrial cancer cells by targeting ARF6, NEDD9 and MT1-MMP.Sana Waheed, Batsukh Dorjbal, Chad A Hamilton, G Larry Maxwell, Gustavo C Rodriguez
Oncotarget. 2025-07-25 - 9 citationsMetformin for patients with advanced stage ovarian cancer: A randomized phase II placebo-controlled trial.Iris L Romero, Ernst Lengyel, Andrea E Wahner Hendrickson, Gustavo C Rodriguez, Charles A Leath 3rd
Gynecologic Oncology. 2025-03-01
Press Mentions
Bright Pink's Lindsay Avner: 'I Had My Ovaries and Uterus Removed 6 Months After Giving Birth'March 6th, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: